UTMD שולי רווח נקי ממכירות Utah Medical Products

Utah Medical Products (UTMD) operates in the protected neonatology segment, where demand remains independent of GDP fluctuations. In-house catheter production minimizes external risks, limiting outsourcing solely to the procurement of plastics. High line automation supports profitability, although the niche market constrains expansion rates. The net profit margin demonstrates the business's resilience, and its current level is 30.50.
פילוחי נתונים אנליטיים מרוכזים עבור Utah Medical Products (UTMD)

Utah Medical Products (UTMD) strategy of producing high-margin niche products combined with strict cost control is directly reflected in the value of 30.50. This ratio measures the share of net profit in total revenue, allowing investors to assess the efficiency of converting sales into real capital, which the net margin structure on the GURU.Markets platform clearly demonstrates.